FI833424A7 - Foerbaettringar i och beroerande benzimidazoler - Google Patents

Foerbaettringar i och beroerande benzimidazoler Download PDF

Info

Publication number
FI833424A7
FI833424A7 FI833424A FI833424A FI833424A7 FI 833424 A7 FI833424 A7 FI 833424A7 FI 833424 A FI833424 A FI 833424A FI 833424 A FI833424 A FI 833424A FI 833424 A7 FI833424 A7 FI 833424A7
Authority
FI
Finland
Prior art keywords
beroerande
benzimidazoler
foerbaettringar
och
och beroerande
Prior art date
Application number
FI833424A
Other languages
English (en)
Finnish (fi)
Other versions
FI833424A0 (fi
Inventor
Wayne Alfred Spitzer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI833424A0 publication Critical patent/FI833424A0/fi
Publication of FI833424A7 publication Critical patent/FI833424A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI833424A 1982-09-27 1983-09-23 Foerbaettringar i och beroerande benzimidazoler FI833424A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/424,784 US4492708A (en) 1982-09-27 1982-09-27 Antiviral benzimidazoles

Publications (2)

Publication Number Publication Date
FI833424A0 FI833424A0 (fi) 1983-09-23
FI833424A7 true FI833424A7 (fi) 1984-03-28

Family

ID=23683858

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833424A FI833424A7 (fi) 1982-09-27 1983-09-23 Foerbaettringar i och beroerande benzimidazoler

Country Status (13)

Country Link
US (1) US4492708A (en:Method)
EP (1) EP0111993A3 (en:Method)
JP (1) JPS5980666A (en:Method)
KR (1) KR840006215A (en:Method)
AU (1) AU1956683A (en:Method)
DD (1) DD207714A5 (en:Method)
DK (1) DK438983D0 (en:Method)
FI (1) FI833424A7 (en:Method)
GB (1) GB2127408B (en:Method)
GR (1) GR79047B (en:Method)
PL (1) PL243905A1 (en:Method)
PT (1) PT77398B (en:Method)
ZA (1) ZA836958B (en:Method)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728741A (en) * 1985-01-08 1988-03-01 Smithkline Beckman Corporation 1-substituted-2-mercapto benzimidazole compounds and intermediates
HU193951B (en) * 1985-03-11 1987-12-28 Richter Gedeon Vegyeszet Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them
FR2593177B1 (fr) * 1986-01-20 1988-04-01 Novapharme Nouveaux benzimidazo
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
US5272167A (en) * 1986-12-10 1993-12-21 Schering Corporation Pharmaceutically active compounds
US5750532A (en) * 1986-12-10 1998-05-12 Schering Corporation Pharmaceutically active compounds
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
KR920701167A (ko) * 1989-07-07 1992-08-11 에릭 에스. 딕커 약제학적 활성 화합물
TW203049B (en:Method) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US5594003A (en) * 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5602127A (en) * 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
US5210091A (en) * 1991-06-24 1993-05-11 Neurosearch A/S Imidazole compounds and their use
DK0520200T3 (da) * 1991-06-24 1998-09-23 Neurosearch As Imadazol-forbindelser, deres fremstilling og anvendelse
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
CN1220601A (zh) * 1996-06-05 1999-06-23 伊莱利利公司 抗病毒化合物
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
EP1361210B1 (en) * 1996-08-12 2008-12-24 Celgene Corporation Novel immunotherapeutic agents and their use in the reduction of cytokine levels
AU6031898A (en) * 1997-01-22 1998-08-07 Eli Lilly And Company Anti-viral compounds
JP2002503253A (ja) * 1997-06-04 2002-01-29 イーライ・リリー・アンド・カンパニー 抗ウイルス化合物
US5990146A (en) * 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
US7132438B2 (en) * 2001-10-09 2006-11-07 Amgen Inc. Benzimidazole derivatives
US7470723B2 (en) * 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof
NZ542407A (en) * 2003-03-05 2008-08-29 Celgene Corp Diphenylethylene compounds and uses thereof
US8044073B2 (en) 2003-12-18 2011-10-25 Tibotec Pharmaceuticals Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
BRPI0506817A (pt) * 2004-01-12 2007-05-29 Cytopia Res Pty Ltd inibidores seletivos de quinase
CN101052630A (zh) * 2004-09-03 2007-10-10 细胞基因公司 取代的杂环化合物和其用途
EP2308852A1 (de) 2005-08-21 2011-04-13 Abbott GmbH & Co. KG 5-Ring-Heteroaromaten-Verbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
FR2892719B3 (fr) * 2005-11-02 2008-01-18 Sep Innovaterm Barriere physico-chimique anti-termites constituee par du beton dans lequel a ete incorpore dans toute la masse un insecticide contre les termites
US7977365B2 (en) * 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
US8871746B2 (en) 2006-03-02 2014-10-28 Kineta Four, LLC Antiviral drugs for treatment of arenavirus infection
EP1988776B1 (en) * 2006-03-02 2012-08-08 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
KR101585584B1 (ko) 2007-08-27 2016-01-14 키네타 포 엘엘씨 아레나바이러스 감염을 치료하기 위한 항바이러스 약물
WO2012070068A2 (en) * 2010-11-24 2012-05-31 Sequent Scientific Limited Process for preparation of triclabendazole
WO2012070069A2 (en) * 2010-11-24 2012-05-31 Sequent Scientific Limited A process for preparation of albendazole
WO2016025744A1 (en) * 2014-08-13 2016-02-18 University Of Virginia Patent Foundation Cancer therapeutics
WO2019031990A1 (ru) * 2017-08-07 2019-02-14 Закрытое Акционерное Общество "Биокад" Новые гетероциклические соединения как ингибиторы cdk8/19
WO2021189080A1 (en) * 2020-03-18 2021-09-23 The Board Of Regents Of The University Of Texas System Methods and compositions for the treatment of influenza

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1384313A (fr) * 1963-02-09 1965-01-04 Schering Ag Nouveaux dérivés du benzimidazole et leur préparation
GB1045534A (en) * 1963-02-09 1966-10-12 Schering Ag New 1-benzyl-5,6-dialkoxy benzimidazoles and a process for their manufacture
US3336191A (en) * 1966-03-11 1967-08-15 Smith Kline French Lab Anthelmintic 2-amidobenzimidazoles
FR1513160A (fr) * 1966-03-24 1968-02-09 Alfa Laval Ab Centrifugeuse
US3936702A (en) * 1972-02-24 1976-02-03 Micro Devices Corporation Electrical protection means
US3825537A (en) * 1972-02-28 1974-07-23 Squibb & Sons Inc 1-thiazolin-2-yl(or thiazin-2-yl)-2-aminobenzimidazoles and derivatives thereof
US3813409A (en) * 1972-07-31 1974-05-28 Squibb & Sons Inc Benzimidazolinone compounds
US4026936A (en) * 1975-08-07 1977-05-31 Hoffmann-La Roche Inc. Anthelmintic pyridine and thiazole substituted benzimidazole carbamates
MX3654E (es) * 1975-08-28 1981-04-14 Lilly Co Eli Procedimiento para preparar compuestos de sulfonilbencimidazol
US4174454A (en) * 1975-08-28 1979-11-13 Eli Lilly And Company Alkylidenylmethyl-substituted 1-sulfonylbenzimidazoles
CA1076582A (en) * 1975-10-28 1980-04-29 Charles J. Paget Antiviral thiazolinyl or thiazinyl ketobenzimidazoles
US4008243A (en) * 1975-11-19 1977-02-15 Eli Lilly And Company Antiviral thiazolinyl or thiazinyl benzimidazole esters
LU75684A1 (en:Method) * 1976-08-27 1978-04-13
US4191832A (en) * 1979-03-12 1980-03-04 Eli Lilly And Company Separation of syn and anti oximes of 1-sulfonyl-2-aminobenzimidazoles
US4230868A (en) * 1979-04-17 1980-10-28 Eli Lilly And Company α-Alkyl-α-hydroxybenzyl-substituted 1-sulfonylbenzimidazoles
US4316021A (en) * 1979-08-13 1982-02-16 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles
US4338329A (en) * 1979-11-14 1982-07-06 Eli Lilly And Company Antiviral method employing 1-sulfonylbenzimidazoles
US4338315A (en) * 1979-11-14 1982-07-06 Eli Lilly And Company Antiviral method employing thiazinyl benzimidazole derivatives

Also Published As

Publication number Publication date
EP0111993A2 (en) 1984-06-27
GB2127408A (en) 1984-04-11
DK438983D0 (da) 1983-09-26
US4492708A (en) 1985-01-08
DD207714A5 (de) 1984-03-14
PT77398B (en) 1986-03-20
FI833424A0 (fi) 1983-09-23
EP0111993A3 (en) 1984-07-25
AU1956683A (en) 1984-04-05
JPS5980666A (ja) 1984-05-10
GR79047B (en:Method) 1984-10-02
PT77398A (en) 1983-10-01
ZA836958B (en) 1985-04-24
KR840006215A (ko) 1984-11-22
PL243905A1 (en) 1985-01-30
GB2127408B (en) 1986-05-14
GB8325360D0 (en) 1983-10-26

Similar Documents

Publication Publication Date Title
FI833424A0 (fi) Foerbaettringar i och beroerande benzimidazoler
FI824321L (fi) Oeverdrag foer en roekningsprodukt och foerfarande
FI824319L (fi) Oeverdrag foer en roekningsprodukt och foerfarande
FI824320A0 (fi) Oeverdrag foer en roekningsprodukt och foerfarande
FI831097A0 (fi) Kirurgiskt krampfaestningsinstrument och kassett foer detta
FI831591L (fi) Azolylmetyloxiraner deras framstaellningsfoerfarande och dessainnehaollande fungicider
FI821571A0 (fi) Foerpackningsaemne och foerpackningsfoerfarande
FI830078A0 (fi) Askorbinsyraetrar och liknande foereningar
FI824126A0 (fi) Foerfarande i laonghaolbergborrning och borrstaongsystem
FI831342L (fi) Verktygsanordning foer spaorstampning, -planing och sidoriktning
FI831085A0 (fi) Rakhyvel och rakaggregat foer rakhyvel
FI833702A7 (fi) Anordning foer styrning och signaloeverfoering i en transportanordning
FI830846L (fi) Anslutningsorgan foer kabelledare och intagstraodskabel
FI831589L (fi) Trifunktionell ledningsfoerdelarenhet och uttag foer denna
FI833436A0 (fi) Elektrohydrauliska drivorgan foer lindnings- och avlindningsmaskiner i prosesslinje och motsvarandemaskiner
FI830779A0 (fi) Eldretarderande sammansatta fibrer och foerfarande foer deras framstaellning
FI831771L (fi) Vaeggreglar och kopplingsdon foer dessa
FI830482L (fi) Cylindriskt skaerverktyg och haollaranordning foer detta
FI830336L (fi) Herbisida heterocyckliska foereningar och blandningar
FI832069A0 (fi) Aminbenzamidderivat och deras framstaellning
FI821383A0 (fi) Foerfarande och anordning foer tandroentgenavbildning
FI65586B (fi) Saekerhetskoppling foer baotar motorslaedar och liknande
FI820384A7 (fi) Foerpackning och foerpackningsfoerfarande
FI822804A0 (fi) Stomme foer ventilgrupper foer uppvaermnings- och bruksvattensystem och liknande
FI822805A0 (fi) Stomme foer ventilgrupper foer uppvaermnings- och bruksvattensystem och liknande

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: ELI LILLY AND COMPANY